首页> 外文期刊>Clinical oncology >The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy.
【24h】

The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy.

机译:术前放化疗后直肠癌淋巴结分期的可靠性。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: To determine the prognostic significance of the nodal stage and number of nodes recovered in the surgical specimen after preoperative synchronous chemoradiation (SCRT) and surgery for locally advanced or unresectable rectal cancer. MATERIALS AND METHODS: One hundred and eighty-two consecutive patients with locally advanced or unresectable (T3/T4) rectal carcinomas were entered on a prospective database and treated in this department with preoperative chemoradiation, followed 6-12 weeks later by surgical resection. Most patients received chemotherapy in the form of low-dose folinic acid and 5-fluorouracil (5-FU) 350 mg/m2 via a 60-min infusion on days 1-5 and 29-33 of a course of pelvic radiotherapy delivered at a dose of 45 Gy in 25 fractions over 33 days to a planned volume. After resection, patients with a positive circumferential margin (< or = 1 mm), extranodal deposits or Dukes' C histology received adjuvant 5-FU-based-chemotherapy (n = 40). RESULTS: After SCRT, 161 patients underwent resection. Twenty-one patients remained unresectable or refused an exenterative operation. Median follow-up is 36 months. Down-staging was achieved in most patients, with 19 having a complete pathological response (pT0). The median number of lymph nodes recovered for all patients was five (range 0-21). The 3-year survival rate for node-positive patients is 47%, for node-negative patients with less than three lymph nodes recovered is 62% and for node-negative patients with three or more lymph nodes recovered is 70%. Compared with node-positive patients, simple regression models revealed a reduced hazard ratio (HR) of 0.72 (0.36-1.43) for node-negative patients with less than three nodes recovered and 0.48 (0.26-0.89) for node-negative patients with three or more lymph nodes recovered. In a multivariate model, including nodal status, excision status, age and sex only positive excision margins significantly predicted a poor outcome: HR = 3.05 (1.55-5.97). CONCLUSIONS: The number of nodes found after preoperativechemoradiation is a significant prognostic factor by univariate analysis. In this study, patients with node-negative histology, and at least three nodes recovered, had better long-term survival than patients in whom two or less nodes were recovered or with positive nodes. This effect was attenuated by the inclusion of excision status in multivariate models.
机译:目的:确定术前同步化学放疗(SCRT)和局部晚期或不可切除直肠癌手术后,在手术标本中淋巴结分期和结节数目的预后意义。材料与方法:将182例局部晚期或不可切除(T3 / T4)直肠癌的连续患者输入前瞻性数据库,并在该科进行术前放化疗,然后在6-12周后进行手术切除。大多数患者在盆腔放疗过程的第1-5天和第29-33天通过60分钟输注以低剂量亚叶酸和5-氟尿嘧啶(5-FU)350 mg / m2的形式接受化疗。在33天内分45剂服用45 Gy剂量至计划剂量。切除后,外周切缘阳性(<或= 1 mm),结外沉积或Dukes'C组织学检查的患者接受了基于5FU的辅助化疗(n = 40)。结果:SCRT后161例患者接受了切除术。 21名患者仍无法切除或拒绝行强行手术。中位随访时间为36个月。在大多数患者中,分期降低了,其中19位具有完全的病理反应(pT0)。所有患者恢复的淋巴结的中位数为五(范围为0-21)。淋巴结阳性患者的3年生存率为47%,淋巴结少于三个的淋巴结阴性患者的62%,淋巴结三个或更多淋巴结阴性的患者的3年生存率为70%。与淋巴结阳性患者相比,简单的回归模型显示,对于少于三个淋巴结的淋巴结阴性患者,危险比(HR)降低为0.72(0.36-1.43),对于具有三个淋巴结阴性患者,其风险比降低为0.48(0.26-0.89)或更多的淋巴结恢复。在包括淋巴结状态,切除状态,年龄和性别在内的多变量模型中,仅阳性切除切缘可显着预测不良结局:HR = 3.05(1.55-5.97)。结论:术前放化疗后发现的结节数目是单因素分析的重要预后因素。在这项研究中,淋巴结阴性且至少三个淋巴结得以恢复的患者比两个或两个以下淋巴结被恢复或淋巴结阳性的患者具有更好的长期生存率。通过在多变量模型中包含切除状态,减弱了这种影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号